Related Experiment Video
Updated: Mar 9, 2026

07:03
Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples
Published on: October 2, 2020
5.2K
Tissue Factor promotes breast cancer stem cell activity in vitro
Hudhaifah Shaker1, Hannah Harrison2, Robert Clarke3
1The University of Manchester, Manchester Academic Health Science Centre, Department of Academic Surgery, University Hospital of South Manchester, Manchester, UK.
Oncotarget
|December 30, 2016
Summary
Tissue Factor (TF) promotes breast cancer stem cell (CSC) activity. Inhibiting TF may reduce CSC function and tumor growth. This study investigated TF
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- Cancer stem cells (CSCs) drive tumor initiation and metastasis.
- Tissue Factor (TF), a clotting protein, is implicated in cancer progression and metastasis.
- Potential link between TF expression and CSC activity requires investigation.
Purpose of the Study:
- To determine if Tissue Factor (TF) enhances breast cancer stem cell (CSC) activity in vitro.
- To investigate the role of TF in CSC self-renewal and tumor-initiating properties.
Main Methods:
- Compared TF expression in CSC-enriched vs. unselected human breast cancer cell lines.
- Assessed CSC activity via mammosphere formation, holoclone formation, and ALDH1 activity.
- Utilized FACS sorting, TF knockdown (siRNA), and TF overexpression (cDNA) models.
- Examined the effect of FVIIa (TF pathway activator) on CSC markers.
Main Results:
- Increased TF expression observed in anoikis-resistant and high ALDH1-activity cells.
- TF-expressing and TF-overexpressing cells exhibited enhanced CSC activity.
- TF knockdown significantly reduced CSC activity.
- FVIIa stimulation dose-dependently increased CSC activity, an effect blocked by TF siRNA.
Conclusions:
- Breast CSCs exhibit increased activity correlated with higher TF expression.
- TF signaling pathways are critical for maintaining breast CSC activity in vitro.
- Targeting the TF pathway presents a potential therapeutic strategy against CSCs.
Related Concept Videos
Cancer Stem Cells and Tumor Maintenance
6.2K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.2K
The Tumor Microenvironment
8.0K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K

